Back to search results

TRIAGE-Neuro Survey for Alzheimer's Research Eligibility

This study, called TRIAGE-Neuro, is an observational survey for people interested in participating in industry-sponsored neurology clinical trials, especially those related to Alzheimer's Disease. It aims to understand how many people seeking trials are actually eligible to screen for them. You would complete a survey about your demographics, medical history, and memory/thinking concerns. Some participants might also have vital signs checked, a urine drug screen, and a blood draw. If you are taking memory medications that might affect your eligibility for other trials, study doctors might suggest a "washout period" where you gradually stop taking them. The study is looking for 600 participants aged 18 and older, and you must be able to understand the screening process. The main goal is to see what percentage of people who want to join a trial are found to be clinically appropriate to screen for one, over a period of up to 52 weeks.

Study design
This is an observational study, meaning participants are observed without receiving a specific treatment. It plans to enroll 600 participants.
What's involved
You would complete a survey, and potentially have vital signs, a urine drug screen, and a blood draw. An optional medication washout period may also occur during screening.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome is measured at up to 52 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06104852

Triage Survey for Neurology Research Eligibility

Recruiting
Not specifiedAges 18+Observational
Adams Clinical
~600 participants
Updated 2023-10-27 on ClinicalTrials.gov
What's tested:SurveyOptional Medication Washout

At a glance

Recruiting sites
2 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of the clinical trial seeking population for whom industry-sponsored clinical research is clinically appropriate, as defined as those who go on to screen for a study.
Measured over Up to 52 weeks

Conditions

Alzheimer Disease

Explore related trials

Alzheimer's Disease

Where it's being run

3 sites across 2 states
Massachusetts2
New York1

Who to contact

Sarah J Starling, PhD
[email protected]
6177448542
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participant and study partner (when applicable) have signed an ICF prior to study-specific procedures being performed.
Participant and study partner (when applicable) are at least 18 years old.

Exclusion

Participant lacks the language skills or cognitive ability to understand the screening process.
Participant is pregnant, breast-feeding, or planning to become pregnant.
History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on Columbia-Suicide Severity Rating Scale questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
Moderate or severe substance use disorder within 90 days prior to screening, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
Any condition that in the investigator's opinion makes a participant unsuitable for the study.
Currently employed by Adams Clinical or a first-degree relative of an employee working on this study.

What this trial measures

  • Proportion of the clinical trial seeking population for whom industry-sponsored clinical research is clinically appropriate, as defined as those who go on to screen for a study.Up to 52 weeks